• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物聚磷能力的估算。

Estimation of microbial phosphate-accumulation abilities.

机构信息

Institute of Life Sciences and Bioengineering, Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki, 305-8572, Japan.

Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki, 305-8572, Japan.

出版信息

Sci Rep. 2019 Mar 19;9(1):4879. doi: 10.1038/s41598-018-37752-8.

DOI:10.1038/s41598-018-37752-8
PMID:30890726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6425018/
Abstract

Phosphate binders and dialysis can have harmful side-effects during the treatments of hyperphosphatemia. Therefore, we evaluated the capability of intestinal bacteria (lactic acid bacteria and bifidobacteria) as phosphate-accumulating organisms (PAOs) for phosphate accumulation, with the aim of determining whether PAO-formulated food can prevent hyperphosphatemia in the early stages. However, methods for estimating microbial phosphate-accumulation capacities require significant improvements regarding specificity, cost, and simplicity. The presented method analyzed cell-free broth to assess the phosphate accumulation capability of cells. Active cells and the constructed phosphate-deficient cells were incubated in assay salt media. After incubation, phosphate-deficient cell-free broth was taken as sample and the blank was the active cell-free broth. Therefore, effects of interfering agents and other metabolites were avoided and enhanced the specificity remarkably. Phosphate contents were assessed by reactions with toluidine blue O. In contrast to the case in previous studies, the shift in the first absorbance peak was found to be inversely proportional to the phosphate concentration. The minimum detectable phosphate concentrations for the 11th isolate of Lactobacillus casei JCM 1134 and 8th isolate of Bifidobacterium adolescentis JCM 1275 were determined to be 1.24 and 0.4 mg/L, respectively. Further, the validation results were found to be significant (p-value < 0.05).

摘要

在治疗高磷血症的过程中,磷酸盐结合剂和透析可能会产生有害的副作用。因此,我们评估了肠道细菌(乳酸菌和双歧杆菌)作为聚磷菌(PAO)的能力,以确定 PAO 配方食品是否可以预防高磷血症的早期发生。然而,用于估计微生物聚磷能力的方法在特异性、成本和简单性方面需要显著改进。所提出的方法分析了无细胞培养液,以评估细胞的聚磷能力。将活性细胞和构建的缺磷细胞在盐培养基中孵育。孵育后,取缺磷无细胞培养液作为样品,空白为活性无细胞培养液。因此,避免了干扰剂和其他代谢物的影响,显著提高了特异性。通过与甲苯胺蓝 O 的反应来评估磷酸盐含量。与之前的研究不同,发现第一吸收峰的偏移与磷酸盐浓度成反比。Lactobacillus casei JCM 1134 的第 11 个分离株和 Bifidobacterium adolescentis JCM 1275 的第 8 个分离株的最低可检测磷酸盐浓度分别确定为 1.24 和 0.4mg/L。此外,验证结果具有统计学意义(p 值 < 0.05)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1508/6425018/83660e7db9e8/41598_2018_37752_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1508/6425018/de4a54502001/41598_2018_37752_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1508/6425018/83660e7db9e8/41598_2018_37752_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1508/6425018/de4a54502001/41598_2018_37752_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1508/6425018/83660e7db9e8/41598_2018_37752_Fig2_HTML.jpg

相似文献

1
Estimation of microbial phosphate-accumulation abilities.微生物聚磷能力的估算。
Sci Rep. 2019 Mar 19;9(1):4879. doi: 10.1038/s41598-018-37752-8.
2
A High Throughput Isolation Method for Phosphate-Accumulating Organisms.一种用于聚磷微生物高通量分离的方法。
Sci Rep. 2019 Dec 2;9(1):18083. doi: 10.1038/s41598-019-53429-2.
3
In vitro antiviral activity of Lactobacillus casei and Bifidobacterium adolescentis against rotavirus infection monitored by NSP4 protein production.通过监测NSP4蛋白产生来研究干酪乳杆菌和青春双歧杆菌对轮状病毒感染的体外抗病毒活性。
J Appl Microbiol. 2016 Apr;120(4):1041-51. doi: 10.1111/jam.13069.
4
Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics Able to Block the In Vitro Adherence of Rotavirus in MA104 Cells.青春双歧杆菌(DSM 20083)和干酪乳杆菌(Lafti L26-DSL):能够阻断轮状病毒在 MA104 细胞中体外黏附的益生菌。
Probiotics Antimicrob Proteins. 2018 Mar;10(1):56-63. doi: 10.1007/s12602-017-9277-7.
5
Effects and safety of iron-based phosphate binders in dialysis patients: a systematic review and meta-analysis.铁基磷酸盐结合剂在透析患者中的疗效与安全性:一项系统评价与荟萃分析
Ren Fail. 2015 Feb;37(1):7-15. doi: 10.3109/0886022X.2014.976160. Epub 2014 Oct 28.
6
The effect of NaCl substitution with KCl on proteinase activities of cell-free extract and cell-free supernatant at different pH levels and salt concentrations: Lactobacillus acidophilus and Lactobacillus casei.NaCl 替代为 KCl 对不同 pH 值和盐浓度下无细胞提取物和无细胞上清液中蛋白酶活性的影响:嗜酸乳杆菌和干酪乳杆菌。
J Dairy Sci. 2013 Jan;96(1):40-9. doi: 10.3168/jds.2012-5761. Epub 2012 Oct 22.
7
Gut Bifidobacterium responses to probiotic Lactobacillus casei Zhang administration vary between subjects from different geographic regions.不同地域来源的个体对益生菌干酪乳杆菌 Zhang 干预的肠道双歧杆菌应答存在差异。
Appl Microbiol Biotechnol. 2022 Apr;106(7):2665-2675. doi: 10.1007/s00253-022-11868-4. Epub 2022 Mar 23.
8
Gut microbiota; an overlooked effect of phosphate binders.肠道微生物群;磷酸盐结合剂被忽视的作用。
Eur J Pharmacol. 2020 Feb 5;868:172892. doi: 10.1016/j.ejphar.2019.172892. Epub 2019 Dec 20.
9
Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients.含唾液磷酸结合剂的口香糖可降低透析患者的高磷血症。
J Am Soc Nephrol. 2009 Mar;20(3):639-44. doi: 10.1681/ASN.2008020130. Epub 2008 Nov 19.
10
[Management of hyperphosphatemia in dialysis patients: the role of phosphate binders].[透析患者高磷血症的管理:磷结合剂的作用]
G Ital Nefrol. 2010 Nov-Dec;27 Suppl 52:S47-54.

引用本文的文献

1
Study of the biosynthesis and functionality of polyphosphate in Bifidobacterium longum KABP042.研究长双歧杆菌 KABP042 中多聚磷酸盐的生物合成和功能。
Sci Rep. 2023 Jul 8;13(1):11076. doi: 10.1038/s41598-023-38082-0.
2
Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches.研究不足的高磷血症(慢性肾脏病)治疗靶点和新的生物学方法。
Medicina (Kaunas). 2023 May 16;59(5):959. doi: 10.3390/medicina59050959.
3
Tailored synbiotic powder (functional food) to prevent hyperphosphataemia (kidney disorder).

本文引用的文献

1
Phosphorus recovery from wastewater through microbial processes.通过微生物过程从废水中回收磷。
Curr Opin Biotechnol. 2012 Dec;23(6):878-83. doi: 10.1016/j.copbio.2012.08.001. Epub 2012 Aug 23.
2
Advances in techniques for phosphorus analysis in biological sources.生物样品中磷分析技术的进展。
Curr Opin Biotechnol. 2012 Dec;23(6):852-9. doi: 10.1016/j.copbio.2012.06.002. Epub 2012 Jul 12.
3
A high throughput method and culture medium for rapid screening of phosphate accumulating microorganisms.一种高通量筛选聚磷微生物的方法和培养基。
定制的共生元粉末(功能性食品),以预防高磷血症(肾脏疾病)。
Sci Rep. 2021 Aug 13;11(1):16485. doi: 10.1038/s41598-021-95176-3.
4
Microbial diversity in relation to physico-chemical properties of hot water ponds located in the Yamunotri landscape of Garhwal Himalaya.位于加瓦尔喜马拉雅山脉亚穆纳特里地区景观中的热水塘的微生物多样性与理化性质的关系。
Heliyon. 2020 Sep 6;6(9):e04850. doi: 10.1016/j.heliyon.2020.e04850. eCollection 2020 Sep.
5
The role of gut microbiota in bone homeostasis.肠道微生物群在骨稳态中的作用。
Bone. 2020 Jun;135:115317. doi: 10.1016/j.bone.2020.115317. Epub 2020 Mar 10.
6
A High Throughput Isolation Method for Phosphate-Accumulating Organisms.一种用于聚磷微生物高通量分离的方法。
Sci Rep. 2019 Dec 2;9(1):18083. doi: 10.1038/s41598-019-53429-2.
Bioresour Technol. 2011 Sep;102(17):8057-62. doi: 10.1016/j.biortech.2011.05.045. Epub 2011 May 26.
4
Dynamics of polyphosphate-accumulating bacteria in wastewater treatment plant microbial communities detected via DAPI (4',6'-diamidino-2-phenylindole) and tetracycline labeling.通过4',6'-二脒基-2-苯基吲哚(DAPI)和四环素标记检测污水处理厂微生物群落中聚磷菌的动态变化。
Appl Environ Microbiol. 2009 Apr;75(7):2111-21. doi: 10.1128/AEM.01540-08. Epub 2009 Jan 30.
5
Copper ions stimulate polyphosphate degradation and phosphate efflux in Acidithiobacillus ferrooxidans.铜离子刺激氧化亚铁硫杆菌中的多聚磷酸盐降解和磷酸盐外流。
Appl Environ Microbiol. 2004 Sep;70(9):5177-82. doi: 10.1128/AEM.70.9.5177-5182.2004.
6
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure.慢性肾衰竭患者临床常用磷结合剂的比较
Kidney Int Suppl. 2004 Sep(90):S25-32. doi: 10.1111/j.1523-1755.2004.09005.x.
7
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.维持性血液透析中的矿物质代谢、死亡率和发病率
J Am Soc Nephrol. 2004 Aug;15(8):2208-18. doi: 10.1097/01.ASN.0000133041.27682.A2.